RMTI Company Profile and Key Details
Rockwell Medical, Inc.
RMTI Stock Price Chart
Stock Price Today
Rockwell Medical, Inc. (RMTI) stock declined over -1.72%, trading at $2.01 on NASDAQ, down from the previous close of $2.04. The stock opened at $1.98, fluctuating between $1.92 and $2.02 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iron therapy that replaces iron and maintains hemoglobin in dialysis patients without increasing iron stores. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including blood tubing, fistula needles, dialyzers, drugs, specialized component kits, dressings, cleaning agents, filtration salts, and other supplies used by hemodialysis providers. The company's dialysis concentrate products are used to maintain human life by removing toxins and replacing critical nutrients in the dialysis patient's bloodstream. It is also developing other therapeutic product candidates for the treatment of hospitalized patients with acute heart failure; and home infusion therapy that allows patients to receive intravenous medications at home. Its target customers include medium and small sized dialysis chains and independent dialysis centers. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.
Company Information
| Employees | 237 |
| Beta | 1.5 |
| Sales or Revenue | $83.61M |
| 5Y Sales Change% | -0.728% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
Frequently Asked Questions
Rockwell Medical, Inc. (NASDAQ: RMTI) stock price is $2.01 in the last trading session. During the trading session, RMTI stock reached the peak price of $2.02 while $1.92 was the lowest point it dropped to. The percentage change in RMTI stock occurred in the recent session was -1.72% while the dollar amount for the price change in RMTI stock was -$0.04.
The NASDAQ listed RMTI is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector. Rockwell Medical, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Dr. Mark Strobeck Ph.D.
Pres, Chief Executive Officer & Director
Mr. David J. Kull
Sec.
Dr. Marc L. Hoffman M.D.
Senior Vice President & Chief Medical Officer
Ms. Megan C. Timmins
Executive Vice President, Chief Legal Officer & Sec.
Mr. Timothy T. Chole
Senior Vice President of Sales & Marketing
Mr. Paul E. McGarry
SVice President of Fin. & Chief Accounting Officer
Mr. Jason Finkelstein
Investor Relations Representative
Ms. Heather R. Hunter
Senior Vice President & Chief Corporation Affairs Officer
RMTI's closing price is 75.86% higher than its 52-week low of $1.16 where as its distance from 52-week high of $5.15 is -60.39%.
Number of RMTI employees currently stands at 237.
Official Website of RMTI is: https://www.rockwellmed.com
RMTI could be contacted at phone 248 960 9009 and can also be accessed through its website. RMTI operates from 30142 South Wixom road, Wixom, MI 48393, United States.
RMTI stock volume for the day was 234.31K shares. The average number of RMTI shares traded daily for last 3 months was 705.2K.
The market value of RMTI currently stands at $64.80M with its latest stock price at $2.01 and 32.32M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com